Employers that had been considering expanding how their health plans cover the abortion drug mifepristone to make it easier to get are putting those plans on hold as they watch a legal challenge that has reached the US Supreme Court, an employee benefits attorney says.
Employers had been considering adding coverage of the drug as a pharmacy benefit in addition to covering it under their medical plans, Katie Bjornstad Amin, a principal with Groom Law Group, said in an interview. Adding pharmacy coverage would make the drug available through telemedicine, she said.
But that was before an April 7 order ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.